G01N 33/5085
Of invertebrates
Official title: {of invertebrates}
G01N33/5085 (Of invertebrates) appears on 139 US grants and 259 published applications in this corpus.
Search patents in G01N- Granted patents
- 139
- Published applications
- 259
- Assignees
- 179
- Inventors
- 592
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 2 |
| 2002 | 1 | 17 |
| 2003 | 7 | 22 |
| 2004 | 7 | 12 |
| 2005 | 8 | 16 |
| 2006 | 10 | 11 |
| 2007 | 2 | 5 |
| 2008 | 2 | 11 |
| 2009 | 3 | 9 |
| 2010 | 5 | 3 |
| 2011 | 3 | 6 |
| 2012 | 3 | 13 |
| 2013 | 1 | 5 |
| 2014 | 5 | 14 |
| 2015 | 8 | 9 |
| 2016 | 6 | 9 |
| 2017 | 7 | 7 |
| 2018 | 8 | 9 |
| 2019 | 5 | 13 |
| 2020 | 3 | 12 |
| 2021 | 5 | 8 |
| 2022 | 10 | 11 |
| 2023 | 4 | 11 |
| 2024 | 4 | 9 |
| 2025 | 8 | 9 |
| 2026 | 7 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Microfluidic-based device for in vivo wound infection model and uses thereof25 Aug 2026US 12,716,889 B2City Unversity of Hong Kong
- Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder7 Jul 2026US 12,673,119 B2University of Rochester
- Bacillus thuringiensis toxin receptors and uses thereof17 Mar 2026US 12,577,284 B2Monsanto Technology LLC
- Methods and compositions for improved insect repellency17 Mar 2026US 12,578,324 B2Board of Trustees of Michigan State University
- Method for evaluating biofilm formation, and invertebrate for use in evaluating biofilm formation10 Mar 2026US 12,571,793 B2Meiji Pharmaceutical University
- Method for producing cells for measuring activity of sensor protein1 Oct 2026US 2026/0297510 A1Sumitomo Chemical Company, Limited
- Method and compositions for analyzing toxicity in organisms10 Sep 2026US 2026/0266805 A1vivoVerse, LLC
- Bacillus thuringiensis toxin receptors and uses thereof30 Jul 2026US 2026/0217787 A1Monsanto Technology LLC
- Platforms, systems, and associated processes for measuring lifespan and multiple in vivo molecular biomarkers of aging2 Jul 2026US 2026/0187803 A1Arizona Board of Regents on Behalf of the University of Arizona
- Compositions and methods targeting swip-10 and mblac1 for the therapeutic modulation of copper dyshomeostasis23 Apr 2026US 2026/0110682 A1
Most cited
By later US patents
- Support with collagen base for tissue engineering and manufacture of biomaterials83US 6,974,679 B2Coletica · 2005
- Compound screening methods37US 6,540,996 B1Devgen NV · 2003
- System for axial pattern analysis of multicellular organisms35US 7,116,407 B2Union Biometrica, Inc. · 2006
- Methods of screening compositions for potential insect control activity30US 7,541,155 B2Tyratech, Inc. · 2009
- In vivo assay for identification of antimicrobial agents26US 7,011,946 B2President and Fellows of Harvard College · 2006